George Demetri co-founded IDRx and develops targeted cancer therapies through research at Dana-Farber and Harvard. His work focuses on sarcomas and gastrointestinal stromal tumors, connecting molecular discoveries with clinical trials.
George Demetri co-founded IDRx and develops targeted cancer therapies through research at Dana-Farber and Harvard. His work focuses on sarcomas and gastrointestinal stromal tumors, connecting molecular discoveries with clinical trials.
Career
DCDirector, Sarcoma Center at Dana-Farber Cancer Institute until PresentLeads sarcoma research and clinical care; also serves as Senior Vice President for Experimental Therapeutics.
HMProfessor of Medicine and Co-director, Ludwig Center at Harvard Medical School until Present